Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy [NA]

View source ↗

Summary

A study is evaluating the safety and tolerability of Rituxan (rituximab) in Duchenne Muscular Dystrophy. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Duchenne Muscular Dystrophy (DMD) | NA | Status: NOT_YET_RECRUITING